Literature DB >> 25873363

Targeted Histone Peptides: Insights into the Spatial Regulation of the Methyltransferase PRC2 by using a Surrogate of Heterotypic Chromatin.

Zachary Z Brown1, Manuel M Müller1, Ha Eun Kong1,2, Peter W Lewis3, Tom W Muir4.   

Abstract

Eukaryotic genomes are dynamically regulated through a host of epigenetic stimuli. The substrate for these epigenetic transactions, chromatin, is a polymer of nucleosome building blocks. In native chromatin, each nucleosome can differ from its neighbors as a result of covalent modifications to both the DNA and the histone packaging proteins. The heterotypic nature of chromatin presents a formidable obstacle to biochemical studies seeking to understand the role of context on epigenetic regulation. A chemical approach to the production of heterotypic chromatin that can be used in such studies is introduced. This method involves the attachment of a user-defined modified histone peptide to a designated nucleosome within the polymer by using a peptide nucleic acid (PNA) targeting compound. This strategy was applied to dissect the effect of chromatin context on the activity of the histone methyltransferase PRC2. The results show that PRC2 can be stimulated to produce histone H3 methylation from a defined nucleation site.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  chromatin; epigenetics; histones; peptide nucleic acids; peptides

Mesh:

Substances:

Year:  2015        PMID: 25873363      PMCID: PMC4617617          DOI: 10.1002/anie.201500085

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  17 in total

Review 1.  Expression and purification of recombinant histones and nucleosome reconstitution.

Authors:  K Luger; T J Rechsteiner; T J Richmond
Journal:  Methods Mol Biol       Date:  1999

Review 2.  Recognition of the DNA minor groove by pyrrole-imidazole polyamides.

Authors:  Peter B Dervan; Benjamin S Edelson
Journal:  Curr Opin Struct Biol       Date:  2003-06       Impact factor: 6.809

Review 3.  Recognition of chromosomal DNA by PNAs.

Authors:  Kunihiro Kaihatsu; Bethany A Janowski; David R Corey
Journal:  Chem Biol       Date:  2004-06

4.  Histone methylation by PRC2 is inhibited by active chromatin marks.

Authors:  Frank W Schmitges; Archana B Prusty; Mahamadou Faty; Alexandra Stützer; Gondichatnahalli M Lingaraju; Jonathan Aiwazian; Ragna Sack; Daniel Hess; Ling Li; Shaolian Zhou; Richard D Bunker; Urs Wirth; Tewis Bouwmeester; Andreas Bauer; Nga Ly-Hartig; Kehao Zhao; Homan Chan; Justin Gu; Heinz Gut; Wolfgang Fischle; Jürg Müller; Nicolas H Thomä
Journal:  Mol Cell       Date:  2011-05-06       Impact factor: 17.970

Review 5.  Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers.

Authors:  Ping Chi; C David Allis; Gang Greg Wang
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

Review 6.  Spreading chromatin into chemical biology.

Authors:  C David Allis; Tom W Muir
Journal:  Chembiochem       Date:  2011-01-11       Impact factor: 3.164

7.  Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma.

Authors:  Peter W Lewis; Manuel M Müller; Matthew S Koletsky; Francisco Cordero; Shu Lin; Laura A Banaszynski; Benjamin A Garcia; Tom W Muir; Oren J Becher; C David Allis
Journal:  Science       Date:  2013-03-28       Impact factor: 47.728

Review 8.  The Polycomb complex PRC2 and its mark in life.

Authors:  Raphaël Margueron; Danny Reinberg
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

Review 9.  The role of EZH2 in tumour progression.

Authors:  C-J Chang; M-C Hung
Journal:  Br J Cancer       Date:  2011-12-20       Impact factor: 7.640

10.  Role of the polycomb protein EED in the propagation of repressive histone marks.

Authors:  Raphael Margueron; Neil Justin; Katsuhito Ohno; Miriam L Sharpe; Jinsook Son; William J Drury; Philipp Voigt; Stephen R Martin; William R Taylor; Valeria De Marco; Vincenzo Pirrotta; Danny Reinberg; Steven J Gamblin
Journal:  Nature       Date:  2009-09-20       Impact factor: 49.962

View more
  5 in total

Review 1.  Oncogenic Mechanisms of Histone H3 Mutations.

Authors:  Daniel N Weinberg; C David Allis; Chao Lu
Journal:  Cold Spring Harb Perspect Med       Date:  2017-01-03       Impact factor: 6.915

2.  S-adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3.

Authors:  Hariharan Jayaram; Dominik Hoelper; Siddhant U Jain; Nico Cantone; Stefan M Lundgren; Florence Poy; C David Allis; Richard Cummings; Steven Bellon; Peter W Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

Review 3.  Recognition of cancer mutations in histone H3K36 by epigenetic writers and readers.

Authors:  Brianna J Klein; Krzysztof Krajewski; Susana Restrepo; Peter W Lewis; Brian D Strahl; Tatiana G Kutateladze
Journal:  Epigenetics       Date:  2018-08-23       Impact factor: 4.528

4.  PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism.

Authors:  Siddhant U Jain; Truman J Do; Peder J Lund; Andrew Q Rashoff; Katharine L Diehl; Marcin Cieslik; Andrea Bajic; Nikoleta Juretic; Shriya Deshmukh; Sriram Venneti; Tom W Muir; Benjamin A Garcia; Nada Jabado; Peter W Lewis
Journal:  Nat Commun       Date:  2019-05-13       Impact factor: 14.919

5.  A two-state activation mechanism controls the histone methyltransferase Suv39h1.

Authors:  Manuel M Müller; Beat Fierz; Lenka Bittova; Glen Liszczak; Tom W Muir
Journal:  Nat Chem Biol       Date:  2016-01-25       Impact factor: 15.040

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.